| The race of 10 synthetic RNAi-based drugs to the pharmaceutical market R Titze-de-Almeida, C David, SS Titze-de-Almeida Pharmaceutical research 34, 1339-1363, 2017 | 230 | 2017 |
| Technical validation of a reverse-transcription quantitative polymerase chain reaction in vitro diagnostic test for the determination of MiR-31-3p expression levels in formalin … L Ramon, C David, K Fontaine, E Lallet, C Marcaillou, S Martin-Lannerée, ... Biomarker insights 13, 1177271918763357, 2018 | 21 | 2018 |
| Correction to: the race of 10 synthetic RNAi-based drugs to the pharmaceutical market R Titze-de-Almeida, C David, SS Titze-de-Almeida Pharmaceutical Research 35, 1-2, 2018 | 2 | 2018 |
| The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market (vol 34, pg 1339, 2017) R Titze-de-Almeida, C David, SS Titze-de-Almeida PHARMACEUTICAL RESEARCH 35 (3), 2018 | | 2018 |
| Antibodies to synthetic peptides from the residue 33 to 42 domain of c-Ha-ras p21 block reconstitution of the protein with different efectors p 3904-10. Rey I., Soubigou P., Debussche L., David C., Morgat A., Bost P.E ... | | |
